Loading clinical trials...
Loading clinical trials...
A Two-Period Trial (Open-Label and Randomized Placebo-Controlled Substitution) of Droxidopa Treatment in Adults With ADHD With Co-administration of Carbidopa
Conditions
Interventions
Droxidopa+Carbidopa
Locations
1
United States
VA New York Harbor Healthcare System/New York University Langone Medical Center
New York, New York, United States
Start Date
October 1, 2009
Primary Completion Date
May 1, 2011
Completion Date
July 1, 2011
Last Updated
April 18, 2024
NCT07189442
NCT06123741
NCT06847165
NCT04175041
NCT07459699
NCT07439276
Lead Sponsor
Chelsea Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions